MOMENTUM 3 Continued Access Protocol
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1685 participants.
Also called NCT02892955
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,685 participants
- Sponsor
- Registry
-
NCT02892955
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02892955. Allocation not applicable; no masking; primary purpose treatment. Start 2016-08 (actual); primary completion 2020-12 (actual). Results posted on 2022-03-03.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MOMENTUM 3 Continued Access Protocol
- Acronym
- MOMENTUM 3 CAP
- Condition
- Advanced Refractory Left Ventricular Heart Failure
- Intervention (Device)
- HeartMate 3 LVAS
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct02892955- Content hash
1393ff59b6cac1753d963e71a9cd56d2c5ebdcb40509924d141447ab3a005490